Journal of vascular and interventional radiology : JVIR
-
J Vasc Interv Radiol · Dec 2005
Randomized Controlled Trial Multicenter StudyUse of the peripheral cutting balloon to treat hemodialysis-related stenoses.
To compare the effectiveness and safety of use of the peripheral cutting balloon (PCB) versus standard percutaneous transluminal angioplasty (PTA) for the treatment of hemodialysis-related stenoses. ⋯ This prospective, randomized trial comparing use of the PCB versus standard PTA for treatment of hemodialysis-related venous stenoses demonstrated that the PCB provides equivalent 6-month patency to PTA for stenotic and thrombosed grafts.
-
J Vasc Interv Radiol · Dec 2005
Randomized Controlled TrialPain and anxiety during interventional radiologic procedures: effect of patients' state anxiety at baseline and modulation by nonpharmacologic analgesia adjuncts.
To assess how patients' underlying anxiety affects their experience of distress, use of resources, and responsiveness toward nonpharmacologic analgesia adjunct therapies during invasive procedures. ⋯ Patients' state anxiety level is a predictor of trends in procedural pain and anxiety, need for medication, and procedure duration. Low and high state anxiety groups profit from the use of nonpharmacologic analgesia adjuncts but those with high state anxiety levels have the most to gain.
-
J Vasc Interv Radiol · Dec 2005
Comparative Study Clinical TrialComparison of SMART stent placement for arteriovenous graft salvage versus successful graft PTA.
To compare the SMART (shape memory alloy recoverable technology) stent with percutaneous transluminal angioplasty (PTA) alone in hemodialysis access venous stenoses. ⋯ Implantation of the SMART stent is safe and effective for the treatment of residual or rapidly recurrent dialysis access venous stenoses and is associated with better patency than PTA alone.
-
J Vasc Interv Radiol · Dec 2005
Comparative StudyHepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.
The optimal embolic agent for transhepatic arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) has not been identified. This study reports outcomes of TACE for HCC with Gelfoam powder and polyvinyl alcohol (PVA). ⋯ In similar patient groups, survival after treatment of HCC with TACE with Gelfoam powder or PVA and Ethiodol was similar.